Skip to content

Trial · Interventional

CompletedPhase 4Registry data

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

Overview

Status
Completed
Phase
Phase 4
Enrollment
160 participants (actual)
Sponsor
Cairo University · Other
Design
Randomized · Double masking
Countries
1 country

Egypt

Start
20 Jul 2016
Primary completion
2 Jun 2019
Completion
1 Jul 2019
First posted
5 Jul 2019
Last update posted
5 Jul 2019
Conditions
Assisted Reproduction

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
20162017201820192020
  1. Ph 4

    Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

    NCT04008966

    20 Jul 2016 to 1 Jul 2019

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

All participants started with a combination of recombinant FSH 300 U and urinary Gn 150 U from the 2nd day of the cycle then the dose was adjusted according to the ovarian response From day 6 of the cycle, follow up using transvaginal ultrasound was done either daily or on alternate days according to the ovarian response. When the leading follicle reached 12 mm, GnRH antagonist was started using Cetrotide 0.25 subcutaneously daily till the day of triggering. Triggering was done when at least 3 follicles larger than 14 mm and at least one of them reached a mean diameter of 17 mm or more. At the day of triggering, women were randomized into 2 groups. Group I (single trigger group) that included 80 women who received triggering in the form of 10,000 IU of HCG intramuscular injection. Group II (Dual trigger group) that included 80 women who received triggering in the form of 10,000 IU of HCG intramuscular injection in addition to GnRH agonist triptorelin 0.2 mg subcutaneously. Ovum pickup was done 34 hours after triggering under the guidance of transvaginal ultrasound. ISM1 culture medium was used for oocyte collection and embryo culture. Transabdominal ultrasound guided embryo transfer was done 3 days after oocyte retrieval using Labotect semirigid catheter by the same expert operator Cycle cancellation was done if day 9 folliculometry revealed less than 2 mature follicles, no oocytes were retrieved or if fertilization failed Luteal phase support was started in all women on the day of oocyte retrieval and continued till the day of serum β-hCG assessment (done 14 days after ET) through administration of 400 mg of natural Progesterone twice daily per vagina . In women with +ve serum β-hCG (\> 5 mIU/ml), transvaginal ultrasound evaluation was done 4 weeks after ET to confirm the presence and number of intrauterine gestational sacs.

Interventions

  • combined oral contaraceptive pillsDrug
  • recombinant FSHDrug
  • Urinaru gonadotropinDrug
  • GnRH antagonistDrug
  • Human chorionic gonadotropinDrug
  • GnRH agonistDrug
  • Ovum pick upProcedure
  • Embryo transferProcedure
  • natural ProgesteroneDrug

Arms2

  • Active comparator

    single trigger

    80 women who received triggering in the form of 10,000 IU of HCG intramuscular injection

  • Active comparator

    Dual trigger

    80 women who received triggering in the form of 10,000 IU of HCG intramuscular injection in addition to GnRH agonist triptorelin 0.2 mg subcutaneously

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. number of mature follicular count

    Time frame · 10 - 14 days of the cycle

    Registry description

    number of follicles larger than 14 mm

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies1

Studies that cite this trial.

Studies with results

1 study on this page

Indexing hint: Randomized controlled trial · 2021

8 results

Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study.

Maged et al. 2021International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetricscited by 28

PMID 33011968DOI 10.1002/ijgo.13405PUB-33011968

Full text at the publisher8 results

Eligibility

Who could join, as posted.

Sex
Female
Age
from 25 Years up to 42 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * women with poor ovarian response candidate for ICSI * women with spontaneous normal menstrual cycle * normal uterine cavity Exclusion Criteria: * women with ovarian cysts * endometriosis * hydrosalpinx * endocrinological disorders as hyperprolactinemia, thyroid or adrenal disorders. * Couples with azospermic male partner * those with severe uncontrolled medical or metabolic disorders

PepBank is a research reference. Talk to a doctor before you use any peptide.